Stay updated on Pembrolizumab in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Pancreatic Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The NIH announcement about the transition from “Artificial Intelligence” to “Super Intelligence” is no longer displayed above the page’s 403 error.
    Difference
    1%
    Check dated 2026-11-08T12:26:19.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T12:53:32.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A banner announces NIH website updates and says that NIH content may use “Super Intelligence” in place of “Artificial Intelligence” during a transition.
    Difference
    1%
    Check dated 2026-10-25T12:57:49.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T12:33:58.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T14:42:16.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error rather than the detailed study record. The view shows a minimal header/footer, indicating restricted access to the page.
    Difference
    18%
    Check dated 2026-09-20T19:21:58.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Pancreatic Cancer Clinical Trial page.